Coya Therapeutics, Inc.COYANASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank40
3Y CAGR-81.6%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-81.6%/yr
Annual compound
Percentile
P40
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$27361.00-99.8%
2024$11.87M+115.7%
2023$5.50M+24.7%
2022$4.41M-
2021$0.00-
2020$0.00-